Visit our events page to stay up to date with the latest events in the cell, gene and immunotherapy community.
VIDEO: How Do You Mend a Broken Heart? Maybe Someday with Stem Cells Made From Your Skin
In a study published online recently in a journal of the American Heart Association, investigator Tim Kamp and his research team showed that they were able to grow working heart-muscle cells from induced pluripotent stem cells.
Jellyfish Protein Helps Regrow Joint Cartilage
Mucin, a protein extracted from Nomura’s jellyfish, has proved highly effective in regrowing cartilage in joints, scientists claim.
VIDEO: Source of Cancer Stem Cells’ Resistance to Radiation Discovered at Stanford
Much to the dismay of patients and physicians, cancer stem cells are relatively resistant to the ionizing radiation often used as therapy for these conditions.
VIDEO: Super-Resolution Microscopy Takes on a Third Dimension
The shapes of some of the tiniest cellular structures are coming into sharper focus from a new imaging technology that produces the best three-dimensional resolution ever seen with an optical microscope.
Stem Cell Research Uncovers Mechanism for Type 2 Diabetes
Taking clues from their stem cell research, investigators have discovered that a signaling pathway involved in normal pancreatic development is also associated with type 2 diabetes.
New Technology Sheds Light on Rise of Blood Cells
German scientists using new imaging technology said on Wednesday they have watched a single cell give rise to blood cells, bolstering understanding of stem cells.
Living Cell Technologies Reports Interim Results Showing Sustained Benefit with DIABECELL(R) Implants for Insulin Dependent Diabetes
The results of 36 to 68 weeks follow-up from the first four patients showed that good blood glucose control was maintained as reflected by a reduction in glycated hemoglobin (% HbA1c) levels from a mean of 8% pre-enrolment to 6.8% at time of clinical review.
Osiris Reports Positive Two-Year Data on Stem Cell Treatment for Acute Myocardial Infarction
Osiris Therapeutics, Inc. recently announced the final two-year results for the Company’s trial evaluating Prochymal for the treatment of acute myocardial infarction.
ViroPharma Reports Disappointing Results of Phase 3 Clinical Trial for Maribavir in Bone Marrow Transplant Patients
ViroPharma Incorporated recently announced that its Phase 3 trial evaluating maribavir used as prophylaxis in allogeneic stem cell, or bone marrow, transplant patients did not achieve its primary endpoint.
ABSTRACTS, REVIEWS AND SPECIAL REPORTS
Long-Term Control of HIV by CCR5 Delta32/Delta32 Stem-Cell Transplantation
The researchers transplanted stem cells from a donor who was homozygous for CCR5 delta32 in a patient with acute myeloid leukemia and HIV-1 infection. The patient remained without viral rebound 20 months after transplantation and discontinuation of antiretroviral therapy.
Telomeres Acquire Embryonic Stem Cell Characteristics in Induced Pluripotent Stem Cells
The researchers try to determine whether telomere chromatin acquires the same characteristics as embryonic stem cells in iPS cells that have been recently derived from older patients.
Inhibition of Intracranial Glioma Growth by Endometrial Regenerative Cells
In this study, the researchers sought to determine whether un-manipulated endometrial regenerative cells would alter the growth of glioma using the aggressive C6/LacZ7 (C6) into Sprague Dawley rat model.
Continuous Single-cell Imaging of Blood Generation from Haemogenic Endothelium
Using new imaging and cell-tracking methods, it is shown that embryonic endothelial cells can be haemogenic and it was possible to detect haemogenic endothelial cells giving rise to blood cells.
Neural Stem Cell– and Schwann Cell–Loaded Biodegradable Polymer Scaffolds Support Axonal Regeneration in the Transected Spinal Cord
This study examines the compatibility of neural stem cells and Schwann cells with the poly-lactic-co-glycolic acid polymer scaffold and quantitatively assesses their potential to promote regeneration after a spinal cord transection injury in rats.
Stable and Non-Disruptive In Vitro/In Vivo Labeling of Mesenchymal Stem Cells by Internalizing Quantum Dots
This study reports that the internalizing Quantum dots generated by their conjugation with an internalizing antibody against an hsp70 family stress chaperone, mortalin, offered an efficient, genetically noninvasive, non toxic and functionally inert way to label mesenchymal stem cells.
Recruit Top Talent
Reach more than 11,000 potential candidates by posting your organization’s career opportunities with Cell Therapy News.
Visit here to post your career opportunities.